Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy.

Cantrell, J E

Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology May 1985 - 723-34 p. digital

Publication Type: Journal Article

0732-183X

10.1200/JCO.1985.3.5.723 doi


Acute Kidney Injury--chemically induced
Adenocarcinoma--drug therapy
Adult
Anemia, Hemolytic--chemically induced
Antibiotics, Antineoplastic--adverse effects
Antigen-Antibody Complex--analysis
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Cardiovascular Diseases--chemically induced
Erythrocyte Transfusion
Female
Hemolytic-Uremic Syndrome--chemically induced
Humans
Immunosuppressive Agents--therapeutic use
Male
Middle Aged
Mitomycin
Mitomycins--adverse effects
Plasmapheresis
Pulmonary Edema--chemically induced
Thrombocytopenia--chemically induced
Transfusion Reaction